FcRn: the neonatal Fc receptor comes of age

The neonatal Fc receptor for IgG (FcRn) has been well characterized in the transfer of passive humoral immunity from a mother to her fetus. In addition, throughout life, FcRn protects IgG from degradation, thereby explaining the long half-life of this class of antibody in the serum. In recent years, it has become clear that FcRn is expressed in various sites in adults, where its potential function is now beginning to emerge. In addition, recent studies have examined the interaction between FcRn and the Fc portion of IgG with the aim of either improving the serum half-life of therapeutic monoclonal antibodies or reducing the half-life of pathogenic antibodies. This Review summarizes these two areas of FcRn biology.

[1]  D. M. Penny,et al.  Stoichiometry of the interaction between the major histocompatibility complex-related Fc receptor and its Fc ligand. , 1999, Biochemistry.

[2]  S L Morrison,et al.  Analysis of the pH dependence of the neonatal Fc receptor/immunoglobulin G interaction using antibody and receptor variants. , 1995, Biochemistry.

[3]  A. Bitonti,et al.  Oral and pulmonary delivery of FSH-Fc fusion proteins via neonatal Fc receptor-mediated transcytosis. , 2005, Human reproduction.

[4]  P. Bjorkman,et al.  Characterization of the 2:1 complex between the class I MHC-related Fc receptor and its Fc ligand in solution. , 1999, Biochemistry.

[5]  R. Ober,et al.  Divergent activities of an engineered antibody in murine and human systems have implications for therapeutic antibodies , 2006, Proceedings of the National Academy of Sciences.

[6]  K. Mostov,et al.  An Fc receptor structurally related to MHC class I antigens , 1989, Nature.

[7]  P. Bjorkman,et al.  Structural basis of pH-dependent antibody binding by the neonatal Fc receptor. , 1998, Structure.

[8]  J. Tso,et al.  Engineered Human IgG Antibodies with Longer Serum Half-lives in Primates* , 2004, Journal of Biological Chemistry.

[9]  R. Hansen,et al.  Intravenous Immunoglobulin Mediates an Increase in Anti-Platelet Antibody Clearance via the FcRn Receptor , 2002, Thrombosis and Haemostasis.

[10]  R. Ober,et al.  Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies. , 2001, International immunology.

[11]  M. Nedergaard,et al.  The blood–brain barrier: an overview Structure, regulation, and clinical implications , 2004, Neurobiology of Disease.

[12]  J. Balthasar,et al.  Pharmacokinetic effects of 4C9, an anti-FcRn antibody, in rats: implications for the use of FcRn inhibitors for the treatment of humoral autoimmune and alloimmune conditions. , 2005, Journal of pharmaceutical sciences.

[13]  L. Hammarström,et al.  The neonatal Fc receptor (FcRn) is expressed in the bovine lung. , 2004, Veterinary immunology and immunopathology.

[14]  T. Azuma,et al.  IgG transport across mucosal barriers by neonatal Fc receptor for IgG and mucosal immunity , 2006, Springer Seminars in Immunopathology.

[15]  Pamela J. Bjorkman,et al.  Crystal structure of the complex of rat neonatal Fc receptor with Fc , 1994, Nature.

[16]  Raimund J. Ober,et al.  Visualizing the Site and Dynamics of IgG Salvage by the MHC Class I-Related Receptor, FcRn1 , 2004, The Journal of Immunology.

[17]  A. Kaser,et al.  Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria. , 2006, The Journal of clinical investigation.

[18]  D. M. Penny,et al.  Identification of critical IgG binding epitopes on the neonatal Fc receptor. , 1997, Journal of molecular biology.

[19]  Sanjiv S Gambhir,et al.  Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments. , 2005, Cancer research.

[20]  R. Junghans,et al.  Functional analysis of the mouse Fcgrt 5' proximal promoter. , 2005, Biochimica et biophysica acta.

[21]  J. M. Osborne,et al.  Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport. , 1996, Journal of immunology.

[22]  K. Badizadegan,et al.  Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line. , 1999, The Journal of clinical investigation.

[23]  R. Hansen,et al.  Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia. , 2002, Blood.

[24]  D. Gitlin,et al.  Maturation of the Maternofoetal Transport System for Human γ-Globulin in the Mouse , 1970, Nature.

[25]  A. Bitonti,et al.  Delivery of an erythropoietin-Fc fusion protein by inhalation in humans through an immunoglobulin transport pathway. , 2005, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[26]  Esther Jacobowitz Israel,et al.  Requirement for a beta 2-microglobulin-associated Fc receptor for acquisition of maternal IgG by fetal and neonatal mice. , 1995, Journal of immunology.

[27]  Jin‐Kyoo Kim,et al.  Localization of the site of the murine IgG1 molecule that is involved in binding to the murine intestinal Fc receptor , 1994, European journal of immunology.

[28]  B. Ober,et al.  The stoichiometry and affinity of the interaction of murine Fc fragments with the MHC class I-related receptor, FcRn. , 1996, Molecular immunology.

[29]  V. H. Lee,et al.  Net absorption of IgG via FcRn-mediated transcytosis across rat alveolar epithelial cell monolayers. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[30]  S. Akilesh,et al.  The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease. , 2004, The Journal of clinical investigation.

[31]  Esther Jacobowitz Israel,et al.  Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells , 1997, Immunology.

[32]  A. Bitonti,et al.  Pulmonary administration of therapeutic proteins using an immunoglobulin transport pathway. , 2006, Advanced drug delivery reviews.

[33]  Raimund J Ober,et al.  Evidence to support the cellular mechanism involved in serum IgG homeostasis in humans. , 2003, International immunology.

[34]  Jin‐Kyoo Kim,et al.  Mapping the site on human IgG for binding of the MHC class I‐related receptor, FcRn , 1999, European journal of immunology.

[35]  P. Bjorkman,et al.  Ligand Valency Affects Transcytosis, Recycling and Intracellular Trafficking Mediated by the Neonatal Fc Receptor , 2006, Traffic.

[36]  R. Herrmann,et al.  Overview of monoclonal antibodies in cancer therapy: present and promise. , 2005, Critical reviews in oncology/hematology.

[37]  C. Sodhi,et al.  IgG binding and expression of its receptor in rat intestine during postnatal development. , 1999, Indian journal of biochemistry & biophysics.

[38]  T. Waldmann,et al.  The mechanism of intestinal uptake and transcellular transport of IgG in the neonatal rat. , 1972, Gut.

[39]  Lee Campbell,et al.  Expression and Transport Functionality of FcRn within Rat Alveolar Epithelium: A Study in Primary Cell Culture and in the Isolated Perfused Lung , 2005, Pharmaceutical Research.

[40]  F. W. Brambell.  The transmission of immunity from mother to young and the catabolism of immunoglobulins. , 1966, Lancet.

[41]  P. Morrissey,et al.  Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[42]  M. Simionescu,et al.  Expression of functionally active FcRn and the differentiated bidirectional transport of IgG in human placental endothelial cells. , 2001, Human immunology.

[43]  P. Bjorkman,et al.  Investigation of the interaction between the class I MHC-related Fc receptor and its immunoglobulin G ligand. , 1994, Immunity.

[44]  E. Ward,et al.  Catabolism of the Murine IgGl Molecule: Evidence that Both CH2‐CH3 Domain Interfaces are Required for Persistence of IgGl in the Circulation of Mice , 1994 .

[45]  A. Bitonti,et al.  Monomeric Fc fusions: impact on pharmacokinetic and biological activity of protein therapeutics. , 2006, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

[46]  J. Haymann,et al.  Characterization and localization of the neonatal Fc receptor in adult human kidney. , 2000, Journal of the American Society of Nephrology : JASN.

[47]  W. L. Wong,et al.  Membrane-anchored human FcRn can oligomerize in the absence of IgG. , 2002, Journal of molecular biology.

[48]  P. Bjorkman,et al.  Crystallization and stoichiometry of binding of a complex between a rat intestinal Fc receptor and Fc. , 1993, Journal of molecular biology.

[49]  V. Lennon,et al.  Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases. , 1999, The New England journal of medicine.

[50]  C. Anderson,et al.  The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[51]  F. W. R. BRAMBELL,et al.  A Theoretical Model of γ-Globulin Catabolism , 1964, Nature.

[52]  J. Ravetch,et al.  Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. , 2001, Science.

[53]  D. Roopenian,et al.  Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases. , 2005, The Journal of clinical investigation.

[54]  N. Copeland,et al.  Mouse MHC class I-like Fc receptor encoded outside the MHC. , 1993, Journal of immunology.

[55]  A. West,et al.  Crystal structure at 2.8 A of an FcRn/heterodimeric Fc complex: mechanism of pH-dependent binding. , 2001, Molecular cell.

[56]  Leonard G. Presta,et al.  High Resolution Mapping of the Binding Site on Human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and Design of IgG1 Variants with Improved Binding to the FcγR* , 2001, The Journal of Biological Chemistry.

[57]  E. Choi,et al.  The MHC Class I-Like IgG Receptor Controls Perinatal IgG Transport, IgG Homeostasis, and Fate of IgG-Fc-Coupled Drugs1 , 2003, The Journal of Immunology.

[58]  Bruce Tidor,et al.  Quantitative methods for developing Fc mutants with extended half-lives. , 2005, Biotechnology and bioengineering.

[59]  J. Fahey,et al.  THE METABOLISM OF NORMAL PLASMA PROTEINS AND GAMMA-MYELOMA PROTEIN IN MICE BEARING PLASMA-CELL TUMORS. , 1961, The Journal of clinical investigation.

[60]  D. Roopenian,et al.  Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells. , 2004, Immunity.

[61]  S. Langermann,et al.  Increasing the Affinity of a Human IgG1 for the Neonatal Fc Receptor: Biological Consequences1 , 2002, The Journal of Immunology.

[62]  Jonghan Kim,et al.  Perspective-- FcRn transports albumin: relevance to immunology and medicine. , 2006, Trends in immunology.

[63]  A. Bitonti,et al.  Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[64]  A. West,et al.  The chicken yolk sac IgY receptor, a functional equivalent of the mammalian MHC-related Fc receptor, is a phospholipase A2 receptor homolog. , 2004, Immunity.

[65]  R. Clynes,et al.  Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. , 2005, Immunity.

[66]  A. Bitonti,et al.  Amelioration of Experimental Autoimmune Myasthenia Gravis in Rats by Neonatal FcR Blockade , 2007, The Journal of Immunology.

[67]  M. Taussig,et al.  Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody—antigen interaction , 1997, Nature Structural Biology.

[68]  Yusuke Suzuki,et al.  FcRn-mediated transcytosis of immunoglobulin G in human renal proximal tubular epithelial cells. , 2002, American journal of physiology. Renal physiology.

[69]  A. Rees,et al.  Isolation and characterization of an Fc receptor from neonatal rat small intestine , 1985, European journal of immunology.

[70]  R. Rodewald.  pH-dependent binding of immunoglobulins to intestinal cells of the neonatal rat , 1976, The Journal of cell biology.

[71]  R. Ober,et al.  Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels , 2005, Nature Biotechnology.

[72]  A. West,et al.  FcRn mediates elongated serum half-life of human IgG in cattle. , 2006, International immunology.

[73]  P. Bjorkman,et al.  Crystal structure at 2.2 Å resolution of the MHC-related neonatal Fc receptor , 1994, Nature.

[74]  D. Holtzman,et al.  IgG-Assisted Age-Dependent Clearance of Alzheimer's Amyloid β Peptide by the Blood–Brain Barrier Neonatal Fc Receptor , 2005, The Journal of Neuroscience.

[75]  Emiko Mizoguchi,et al.  MHC Class I-Related Neonatal Fc Receptor for IgG Is Functionally Expressed in Monocytes, Intestinal Macrophages, and Dendritic Cells1 , 2001, The Journal of Immunology.

[76]  Prof. P. Ehrlich.  Ueber Immunität durch Vererbung und Säugung , 1892, Zeitschrift für Hygiene und Infektionskrankheiten.

[77]  Herren Wu,et al.  Properties of Human IgG1s Engineered for Enhanced Binding to the Neonatal Fc Receptor (FcRn)* , 2006, Journal of Biological Chemistry.

[78]  W. Delano,et al.  Convergent solutions to binding at a protein-protein interface. , 2000, Science.

[79]  D. Pearl,et al.  The Major Histocompatibility Complex–related Fc Receptor for IgG (FcRn) Binds Albumin and Prolongs Its Lifespan , 2003, The Journal of experimental medicine.

[80]  Raimund J Ober,et al.  Exocytosis of IgG as mediated by the receptor, FcRn: an analysis at the single-molecule level. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[81]  Leonard G. Presta,et al.  Mapping of the C1q Binding Site on Rituxan, a Chimeric Antibody with a Human IgG1 Fc , 2000, The Journal of Immunology.

[82]  E. Kristoffersen.  Human placental Fcγ‐binding proteins in the maternofetal transfer of IgG , 1996 .

[83]  J. Deisenhofer.  Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. , 1981, Biochemistry.

[84]  A. West,et al.  Crystal structure and immunoglobulin G binding properties of the human major histocompatibility complex-related Fc receptor(,). , 2000, Biochemistry.

[85]  W. Lencer,et al.  Distribution of the IgG Fc Receptor, FcRn, in the Human Fetal Intestine , 2003, Pediatric Research.

[86]  Leonard G Presta,et al.  Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease. , 2006, International immunology.

[87]  E. Ward,et al.  Delineation of the amino acid residues involved in transcytosis and catabolism of mouse IgG1. , 1997, Journal of immunology.

[88]  J. S. Hunt,et al.  An IgG‐transporting Fc receptor expressed in the syncytiotrophoblast of human placenta , 1996, European journal of immunology.

[89]  Patricia W. Finn,et al.  Receptor-mediated Immunoglobulin G Transport Across Mucosal Barriers in Adult Life , 2002, The Journal of experimental medicine.

[90]  W. Pardridge,et al.  Mediated efflux of IgG molecules from brain to blood across the blood–brain barrier , 2001, Journal of Neuroimmunology.

[91]  N. Simister,et al.  Analysis of the promoter region of the human FcRn gene. , 2000, Biochimica et biophysica acta.

[92]  Jin‐Kyoo Kim,et al.  Abnormally short serum half‐lives of IgG in β2‐microglobulin‐deficient mice , 1996, European journal of immunology.

[93]  M. Simionescu,et al.  Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice. , 1998, International immunology.

[94]  E. Ward,et al.  Multiple roles for the major histocompatibility complex class I- related receptor FcRn. , 2000, Annual review of immunology.

[95]  W. Pardridge,et al.  Expression of the neonatal Fc receptor (FcRn) at the blood–brain barrier , 2002, Journal of neurochemistry.

[96]  Menotti Ruvo,et al.  Prevention of systemic lupus erythematosus in MRL/lpr mice by administration of an immunoglobulin-binding peptide , 2000, Nature Biotechnology.

[97]  N. Tsurushita,et al.  An Engineered Human IgG1 Antibody with Longer Serum Half-Life , 2006, The Journal of Immunology.

[98]  D. Wigley,et al.  Crystal structure of a streptococcal protein G domain bound to an Fab fragment , 1992, Nature.

[99]  R. Ober,et al.  The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humans. , 2001, International immunology.